FR2280390A1 - Preparation pour le traitement des maladies infectieuses, procede pour son obtention et son utilisation - Google Patents

Preparation pour le traitement des maladies infectieuses, procede pour son obtention et son utilisation

Info

Publication number
FR2280390A1
FR2280390A1 FR7523913A FR7523913A FR2280390A1 FR 2280390 A1 FR2280390 A1 FR 2280390A1 FR 7523913 A FR7523913 A FR 7523913A FR 7523913 A FR7523913 A FR 7523913A FR 2280390 A1 FR2280390 A1 FR 2280390A1
Authority
FR
France
Prior art keywords
obtaining
preparation
treatment
infectious diseases
infectious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7523913A
Other languages
English (en)
Other versions
FR2280390B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742437166 external-priority patent/DE2437166C3/de
Application filed by Individual filed Critical Individual
Publication of FR2280390A1 publication Critical patent/FR2280390A1/fr
Application granted granted Critical
Publication of FR2280390B1 publication Critical patent/FR2280390B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
FR7523913A 1974-08-01 1975-07-31 Preparation pour le traitement des maladies infectieuses, procede pour son obtention et son utilisation Granted FR2280390A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742437166 DE2437166C3 (de) 1974-08-01 Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten

Publications (2)

Publication Number Publication Date
FR2280390A1 true FR2280390A1 (fr) 1976-02-27
FR2280390B1 FR2280390B1 (fr) 1980-04-11

Family

ID=5922207

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7523913A Granted FR2280390A1 (fr) 1974-08-01 1975-07-31 Preparation pour le traitement des maladies infectieuses, procede pour son obtention et son utilisation

Country Status (13)

Country Link
US (1) US4053582A (fr)
JP (1) JPS5141420A (fr)
AT (1) AT343797B (fr)
BE (1) BE831691A (fr)
CA (1) CA1057195A (fr)
CH (1) CH614627A5 (fr)
DK (1) DK141835C (fr)
ES (1) ES439966A1 (fr)
FR (1) FR2280390A1 (fr)
GB (1) GB1517540A (fr)
NL (1) NL7509136A (fr)
SE (1) SE7508565L (fr)
ZA (1) ZA754725B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385402A1 (fr) * 1977-04-01 1978-10-27 Anton Mayr Preparation pour le traitement de l'herpes zoster et autres infections de type herpes, ainsi que procede pour sa fabrication
FR2537436A1 (fr) * 1982-12-13 1984-06-15 Texas A & M Univ Sys Procede de regulation de l'appetit et de l'efficacite de l'utilisation des aliments utilisant de l'interferon

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
EP0037441B1 (fr) * 1980-03-10 1984-05-09 Seiji Arakawa Compositions pharmaceutiques utilisables comme immunostimulant cellulaire et comme agent anti-tumeur, procédé de préparation et microorganisme utilisé
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
EP0077063B1 (fr) * 1981-10-13 1988-03-16 Exovir, Inc. Compositions contenant de l'interféron et application de ces compositions dans le traitement des infections herpétiques, lésions prémalignes de la peau, malignités de la peau et psoriasis
EP0080032A3 (fr) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Préparation pharmaceutique pour le traitement de lésions herpétiques
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
CA1320905C (fr) 1986-11-06 1993-08-03 Joseph M. Cummins Traitement d'affections immuno-resistantes
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US4758426A (en) * 1987-06-11 1988-07-19 Ramsdell Bruce V Therapeutic toilet solution and method of dispersion
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5215745A (en) * 1988-04-27 1993-06-01 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
DK0696326T5 (da) 1993-04-30 2003-07-14 Wellstat Biologics Corp Anvendelse af NDV til fremstilling af et medikament til behandling af cancer
FR2707458B1 (fr) * 1993-07-12 1995-10-06 Sagal Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant.
US6140107A (en) * 1996-09-25 2000-10-31 Viva America Marketing, Inc. Organometallic-metabolizing yeast
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
US20030138454A1 (en) * 1997-06-09 2003-07-24 Oxxon Pharmaccines, Ltd. Vaccination method
GB0118532D0 (en) * 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
GB2396814B (en) * 2001-11-30 2006-07-19 Isis Innovation Fowlpox vector
US20050175627A1 (en) * 2003-09-24 2005-08-11 Oxxon Therapeutics Ltd. HIV pharmaccines
DE10349115A1 (de) * 2003-10-22 2005-06-16 Biosyn Arzneimittel Gmbh Kombinationspräparat zur Behandlung der Sepsis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385402A1 (fr) * 1977-04-01 1978-10-27 Anton Mayr Preparation pour le traitement de l'herpes zoster et autres infections de type herpes, ainsi que procede pour sa fabrication
FR2537436A1 (fr) * 1982-12-13 1984-06-15 Texas A & M Univ Sys Procede de regulation de l'appetit et de l'efficacite de l'utilisation des aliments utilisant de l'interferon

Also Published As

Publication number Publication date
DK141835B (da) 1980-06-30
AT343797B (de) 1978-06-12
DK347775A (da) 1976-02-02
JPS5141420A (fr) 1976-04-07
NL7509136A (nl) 1976-02-03
GB1517540A (en) 1978-07-12
ATA598975A (de) 1977-10-15
US4053582A (en) 1977-10-11
SE7508565L (sv) 1976-02-02
DE2437166A1 (de) 1976-02-19
CH614627A5 (fr) 1979-12-14
FR2280390B1 (fr) 1980-04-11
BE831691A (fr) 1975-11-17
DE2437166B2 (de) 1977-01-27
DK141835C (da) 1980-11-10
ZA754725B (en) 1976-06-30
ES439966A1 (es) 1977-03-01
CA1057195A (fr) 1979-06-26

Similar Documents

Publication Publication Date Title
FR2280390A1 (fr) Preparation pour le traitement des maladies infectieuses, procede pour son obtention et son utilisation
FR2273509A1 (fr) Article pour le traitement des menstrues
FR2293449A1 (fr) Polyurethannes anioniques, leur procede de preparation et leur utilisation
FR2286134A1 (fr) Nouvelles urethannoxazolidines, et leur procede de preparation
RO70051A (fr) Procede pour la preparation des 2-tetra-hydrofurfurile-6,7-benzomorphanes
RO72736A (fr) Procede pour la preparation des 2-tetrahydrofurfuryle-6,7-benzomorphanes-5,9-beta-disubstitus
RO68142A (fr) Procede pour la preparation des 4-phenylpyperidines
BE827470A (fr) Procede de traitement de membranes
BE834064A (fr) Procede de preparation de carboxamides de oxo-1,2-benzothiazine-1, 1-dioxydes
FR2276276A1 (fr) Procede de preparation de platre
FR2287435A1 (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4-pyranones-2
BE841018A (fr) Conteneur de traitement
RO66914A (fr) Procede pour la preparation des pyrido-benzodiazepinones
BE844993A (fr) Procede de traitement de la mitraille
FR2278715A1 (fr) Copolymerisats, procede de preparation et utilisation
BE792259A (fr) Procede et nouvelles compositions pour le traitement de la chevelure
BE832516A (fr) Procede de traitement de montmorillonite
RO63021A (fr) Procede pour la preparation des 3-fluorcephalosporines
RO68749A (fr) Procede pour la preparation des 2-amidoimidazoles
FR2296645A1 (fr) 3a, 5a-cyclo-6b-alkoxy-25-hydroxycholest-22-yne et son procede de preparation
RO66020A (fr) Procede pour la preparation des 3-pyperazinoisoquinolines
BE792421A (fr) Agent pour le traitement des hyperlipoproteinemies et son procede de preparation
IT1054437B (it) Calzamaglia e procedimento per la sua fabbricazione
BE825528A (fr) Nouvel agent pour le traitement prophylaxique et therapeutique de deshydratations en medecine veterinaire, procede pour sa preparation et son utilisation
RO72516A (fr) Procede pour la preparation des quinoxalin-1,4-dioxydes

Legal Events

Date Code Title Description
ST Notification of lapse